Sevoflurane partially reverses the decrease in survival caused by TRPV1 antagonism suggesting that sevoflurane may enhance breast cancer cell survival through the activation of TRPV1 Ca2+ channels. The gene discussed is TRPV1; the disease is breast carcinoma.